07:00 EDT Novavax (NVAX) jumps 15% to $7.73 after FDA approves COVID vaccine
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVAX:
- Novavax’s Strategic Positioning and Regulatory Milestones Drive Buy Rating
- FDA approves Novavax COVID-19 vaccine with restrictions
- Novavax COVID-19 vaccine approved by FDA with restrictions, AP News says
- HHS to drop recommendations for routine COVID shots for kids, WSJ reports
- FDA head says vaccine framework being prepared